Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource, 1 online resource.

Language: Englisch

Bibliographic citation: Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens ; volume:21 ; number:1 ; day:22 ; month:5 ; year:2023 ; pages:1-14 ; date:12.2023
Journal of translational medicine ; 21, Heft 1 (22.5.2023), 1-14, 12.2023

Creator: Shen, Luhui
Brown, Justin R.
Johnston, Stephen Albert
Altan, Mehmet
Sykes, Kathryn F.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12967-023-04172-w

URN: urn:nbn:de:101:1-2023091011503779265400

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:03 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Shen, Luhui
Brown, Justin R.
Johnston, Stephen Albert
Altan, Mehmet
Sykes, Kathryn F.
SpringerLink (Online service)

Other Objects (12)

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

FMCGP: frameshift mutation cartesian genetic programming

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Aligning coding sequences with frameshift extension penalties

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

FMCGP: frameshift mutation cartesian genetic programming

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Aligning coding sequences with frameshift extension penalties

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

FMCGP: frameshift mutation cartesian genetic programming

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Aligning coding sequences with frameshift extension penalties

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Predicting response and toxicity to immune checkpoint inhibitors in lung cancer using antibodies to frameshift neoantigens

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

FMCGP: frameshift mutation cartesian genetic programming

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Aligning coding sequences with frameshift extension penalties

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

FMCGP: frameshift mutation cartesian genetic programming

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Aligning coding sequences with frameshift extension penalties

IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma

Severe toxicity from checkpoint protein inhibitors: What intensive care physicians need to know?

Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity

Management of Gastrointestinal Toxicity from Immune Checkpoint Inhibitor

FMCGP: frameshift mutation cartesian genetic programming

Cardiovascular Toxicity of Immune Checkpoint Inhibitors: A Guide for Clinicians

Germline genetic variation and predicting immune checkpoint inhibitor induced toxicity

Neurologic toxicity associated with immune checkpoint inhibitors: a pharmacovigilance study

Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity

Enzymatization of mouse monoclonal antibodies to the corresponding catalytic antibodies

Aligning coding sequences with frameshift extension penalties

Related objects

Reset password